FDA Adverse Event Malfunction Summary report: N

CARPENTIER-EDWARDS PERIMOUNT PLUS PERICARDIAL BIOPROSTHESIS

MDR report key: 3081606 · Received April 29, 2013

Report

Report Number
2015691-2013-19934
Event Type
Malfunction
Date Received
April 29, 2013
Date of Event
March 29, 2013
Report Date
March 29, 2013
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
P860057/S016
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IMPLANTATION OF A TRANSCATHETER HEART VALVE INSIDE A DEGENERATED ONE IS A LESS INVASIVE PROCEDURE TO TREAT VALVULAR DISEASE. STENOSIS OF A BIOPROSTHETIC VALVE IS DEPENDENT ON BOTH PATIENT FACTORS AN INTRINSIC PROPERTIES OF BIOPROSTHETIC VALVES. WITHOUT RETURN OF DEVICE, THE NATURE OF THE REPORTED SEVERE STENOSIS CANNOT BE IDENTIFIED OR EVALUATED. STENOSIS MAY BE DUE TO CALCIFIC TISSUE DEGENERATION, NON-CALCIFIC TISSUE DEGENERATION, AND/OR NON-STRUCTURAL DYSFUNCTION.

Description of Event or Problem · 1

IT WAS REPORTED TO SALES DEPARTMENT BY SURGEON THAT A 27MM EDWARDS CARPENTIER IMPLANTED IN 2006 WAS NOTED ON TEE TO HAVE 2 OF THE 3 LEAFLETS COMPLETELY FUSED AND ONLY ONE LEAFLET MOVING. THE PATIENT UNDERWENT A TRANSAPICAL TRANSCATHETER MITRAL VALVE REPLACEMENT INSIDE THE STENOTIC BIOPROSTHETIC MITRAL VALVE IN A VALVE IN VALVE FASHION. THE OPERATIVE REPORT INDICATES "TEE WAS PERFORMED BY THE ANESTHESIA TEAM, AND THIS SHOWED THAT THE AORTIC VALVE WAS CRITICALLY STENOTIC. IT ALSO SHOWED THAT THE MITRAL VALVE PROSTHESIS WAS HIGHLY DYSFUNCTIONAL, AS 2 OF THE LEAFLETS WERE IMMOBILE AND ONLY 1 LEAFLET OPENED. THE GRADIENTS ACROSS THE MITRAL VALVE WERE OVER 10 MMHG PEAK AND ABOUT 10 MMHG MEAN, SHOWING SEVERE MITRAL STENOSIS....[AFTER VALVE IMPLANTATION] THE PATIENT TOLERATED THIS VERY COMPLEX PROCEDURE...AND RETURNED TO THE INTENSIVE CARE UNITE IN STABLE CONDITION."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
184134 CARPENTIER-EDWARDS PERIMOUNT PLUS PERICARDIAL BIOPROSTHESIS REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES 6900P 5L2076

Patients

Seq Age Sex Outcome Treatment
1 85 YR Hospitalization| L| R